Andrea Riposati is co-founder and CEO of Dante Genomics (formerly Dante Labs), a global genomic information company building and commercializing a new class of transformative health and longevity applications based on whole genome sequencing and AI. Before starting Dante Labs, Andrea was the CEO of Muse Technologies, a B2B digital software and consulting company, and a Sr. Product Manager at Amazon, in Seattle and New York, where he launched the Amazon 3D Printing Store and the Amazon B2B Marketplace. Andrea started his career at Booz Allen Hamilton as a strategy and management consultant in digital and healthcare. Andrea holds a Master’s Degree in Business and Economics summa cum laude from Bocconi University in Milan, Italy, and a Master in Business Administration (MBA) from Harvard University.